AstraZeneca says data support new Seroquel use (Reuters)
Reuters - Anglo-Swedish drugmaker AstraZeneca Plc
said on Friday new clinical trial data underlined the potential
of its schizophrenia drug Seroquel as a treatment for bipolar
disorder, a form of manic depression.
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace